Skip to main content
Erschienen in: CardioVascular and Interventional Radiology 4/2015

01.08.2015 | Review

How to Prepare a Patient for Transarterial Radioembolization? A Practical Guide

verfasst von: Alban Denys, Marc Pracht, Rafael Duran, Boris Guiu, Salim Adib, Ariane Boubaker, Pierre Bize

Erschienen in: CardioVascular and Interventional Radiology | Ausgabe 4/2015

Einloggen, um Zugang zu erhalten

Abstract

Transarterial radioembolization consist in delivering small particles loaded with Yttrium90, a pure beta emitter, in order to treat primary and secondary liver tumors. This treatment needs precaution since inadequate delivery of these beads can lead to severe complications. Moreover, a precise radiation dosing is crucial to achieve a good clinical success and to avoid complications such as radioembolization-induced liver disease. This review describes all the precautions and highlights clinical and technical considerations that need to be taken to avoid complications.
Literatur
1.
Zurück zum Zitat Flynn WJ (1967) The treatment of pulmonary metastases with microspheres of yttrium 90. Minerva Med 58(99):4498–4500PubMed Flynn WJ (1967) The treatment of pulmonary metastases with microspheres of yttrium 90. Minerva Med 58(99):4498–4500PubMed
2.
Zurück zum Zitat Gray BN, Anderson JE, Burton MA et al (1992) Regression of liver metastases following treatment with yttrium-90 microspheres. Aust N Z J Surg 62(2):105–110PubMedCrossRef Gray BN, Anderson JE, Burton MA et al (1992) Regression of liver metastases following treatment with yttrium-90 microspheres. Aust N Z J Surg 62(2):105–110PubMedCrossRef
3.
Zurück zum Zitat Shepherd FA, Rotstein LE, Houle S, Yip TC, Paul K, Sniderman KW (1992) A phase I dose escalation trial of yttrium-90 microspheres in the treatment of primary hepatocellular carcinoma. Cancer 70(9):2250–2254PubMedCrossRef Shepherd FA, Rotstein LE, Houle S, Yip TC, Paul K, Sniderman KW (1992) A phase I dose escalation trial of yttrium-90 microspheres in the treatment of primary hepatocellular carcinoma. Cancer 70(9):2250–2254PubMedCrossRef
4.
Zurück zum Zitat Lau WY, Leung WT, Ho S et al (1994) Treatment of inoperable hepatocellular carcinoma with intrahepatic arterial yttrium-90 microspheres: a phase I and II study. Br J Cancer 70(5):994–999PubMedCentralPubMedCrossRef Lau WY, Leung WT, Ho S et al (1994) Treatment of inoperable hepatocellular carcinoma with intrahepatic arterial yttrium-90 microspheres: a phase I and II study. Br J Cancer 70(5):994–999PubMedCentralPubMedCrossRef
5.
Zurück zum Zitat Roche A, Girish BV, de Baere T et al (2003) Trans-catheter arterial chemoembolization as first-line treatment for hepatic metastases from endocrine tumors. Eur Radiol 13(1):136–140PubMed Roche A, Girish BV, de Baere T et al (2003) Trans-catheter arterial chemoembolization as first-line treatment for hepatic metastases from endocrine tumors. Eur Radiol 13(1):136–140PubMed
6.
Zurück zum Zitat Wang LM, Jani AR, Hill EJ, Sharma RA (2013) Anatomical basis and histopathological changes resulting from selective internal radiotherapy for liver metastases. J Clin Pathol 66(3):205–211PubMedCentralPubMedCrossRef Wang LM, Jani AR, Hill EJ, Sharma RA (2013) Anatomical basis and histopathological changes resulting from selective internal radiotherapy for liver metastases. J Clin Pathol 66(3):205–211PubMedCentralPubMedCrossRef
7.
Zurück zum Zitat Garin E, Lenoir L, Rolland Y et al (2012) Dosimetry based on 99mTc-macroaggregated albumin SPECT/CT accurately predicts tumor response and survival in hepatocellular carcinoma patients treated with 90Y-loaded glass microspheres: preliminary results. J Nucl Med 53(2):255–263PubMedCrossRef Garin E, Lenoir L, Rolland Y et al (2012) Dosimetry based on 99mTc-macroaggregated albumin SPECT/CT accurately predicts tumor response and survival in hepatocellular carcinoma patients treated with 90Y-loaded glass microspheres: preliminary results. J Nucl Med 53(2):255–263PubMedCrossRef
8.
Zurück zum Zitat Elschot M, Vermolen BJ, Lam MG, de Keizer B, van den Bosch MA, de Jong HW (2013) Quantitative comparison of PET and Bremsstrahlung SPECT for imaging the in vivo yttrium-90 microsphere distribution after liver radioembolization. PLoS ONE 8(2):e55742PubMedCentralPubMedCrossRef Elschot M, Vermolen BJ, Lam MG, de Keizer B, van den Bosch MA, de Jong HW (2013) Quantitative comparison of PET and Bremsstrahlung SPECT for imaging the in vivo yttrium-90 microsphere distribution after liver radioembolization. PLoS ONE 8(2):e55742PubMedCentralPubMedCrossRef
9.
Zurück zum Zitat van den Hoven AF, Prince JF, Samim M et al (2014) Posttreatment PET-CT-Confirmed Intrahepatic Radioembolization Performed Without Coil Embolization, by Using the Antireflux Surefire Infusion System. Cardiovasc Intervent Radiol 37(2):523–528PubMedCrossRef van den Hoven AF, Prince JF, Samim M et al (2014) Posttreatment PET-CT-Confirmed Intrahepatic Radioembolization Performed Without Coil Embolization, by Using the Antireflux Surefire Infusion System. Cardiovasc Intervent Radiol 37(2):523–528PubMedCrossRef
10.
Zurück zum Zitat Rose SC, Kikolski SG, Chomas JE (2013) Downstream hepatic arterial blood pressure changes caused by deployment of the surefire antireflux expandable tip. Cardiovasc Intervent Radiol 36(5):1262–1269PubMedCrossRef Rose SC, Kikolski SG, Chomas JE (2013) Downstream hepatic arterial blood pressure changes caused by deployment of the surefire antireflux expandable tip. Cardiovasc Intervent Radiol 36(5):1262–1269PubMedCrossRef
12.
Zurück zum Zitat Lauenstein TC, Heusner TA, Hamami M et al (2011) Radioembolization of hepatic tumors: flow redistribution after the occlusion of intrahepatic arteries. RoFo 183(11):1058–1064PubMedCrossRef Lauenstein TC, Heusner TA, Hamami M et al (2011) Radioembolization of hepatic tumors: flow redistribution after the occlusion of intrahepatic arteries. RoFo 183(11):1058–1064PubMedCrossRef
13.
Zurück zum Zitat Bilbao JI, Garrastachu P, Herraiz MJ et al (2010) Safety and efficacy assessment of flow redistribution by occlusion of intrahepatic vessels prior to radioembolization in the treatment of liver tumors. Cardiovasc Intervent Radiol 33(3):523–531PubMedCrossRef Bilbao JI, Garrastachu P, Herraiz MJ et al (2010) Safety and efficacy assessment of flow redistribution by occlusion of intrahepatic vessels prior to radioembolization in the treatment of liver tumors. Cardiovasc Intervent Radiol 33(3):523–531PubMedCrossRef
14.
Zurück zum Zitat Burgmans MC, Kao YH, Irani FG et al (2012) Radioembolization with infusion of yttrium-90 microspheres into a right inferior phrenic artery with hepatic tumor supply is feasible and safe. J Vasc Interv Radiol 23(10):1294–1301PubMedCrossRef Burgmans MC, Kao YH, Irani FG et al (2012) Radioembolization with infusion of yttrium-90 microspheres into a right inferior phrenic artery with hepatic tumor supply is feasible and safe. J Vasc Interv Radiol 23(10):1294–1301PubMedCrossRef
15.
Zurück zum Zitat Abdelmaksoud MH, Louie JD, Kothary N et al (2011) Embolization of parasitized extrahepatic arteries to reestablish intrahepatic arterial supply to tumors before yttrium-90 radioembolization. J Vasc Interv Radiol 22(10):1355–1362PubMedCrossRef Abdelmaksoud MH, Louie JD, Kothary N et al (2011) Embolization of parasitized extrahepatic arteries to reestablish intrahepatic arterial supply to tumors before yttrium-90 radioembolization. J Vasc Interv Radiol 22(10):1355–1362PubMedCrossRef
16.
Zurück zum Zitat Hamoui N, Minocha J, Memon K et al (2013) Prophylactic embolization of the gastroduodenal and right gastric arteries is not routinely necessary before radioembolization with glass microspheres. J Vasc Interv Radiol 24(11):1743–1745PubMedCrossRef Hamoui N, Minocha J, Memon K et al (2013) Prophylactic embolization of the gastroduodenal and right gastric arteries is not routinely necessary before radioembolization with glass microspheres. J Vasc Interv Radiol 24(11):1743–1745PubMedCrossRef
17.
Zurück zum Zitat Hashimoto M, Heianna J, Tate E, Kurosawa R, Nishii T, Mayama I (2001) The feasibility of retrograde catheterization of the right gastric artery via the left gastric artery. J Vasc Interv Radiol 12(9):1103–1106PubMedCrossRef Hashimoto M, Heianna J, Tate E, Kurosawa R, Nishii T, Mayama I (2001) The feasibility of retrograde catheterization of the right gastric artery via the left gastric artery. J Vasc Interv Radiol 12(9):1103–1106PubMedCrossRef
18.
Zurück zum Zitat Aloia TA, Barakat O, Connelly J et al (2009) Gastric radiation enteritis after intra-arterial yttrium-90 microsphere therapy for early stage hepatocellular carcinoma. Exp Clin Transplant 7(3):141–144PubMed Aloia TA, Barakat O, Connelly J et al (2009) Gastric radiation enteritis after intra-arterial yttrium-90 microsphere therapy for early stage hepatocellular carcinoma. Exp Clin Transplant 7(3):141–144PubMed
19.
Zurück zum Zitat Petroziello MF, McCann JW, Gonsalves CF et al (2011) Side-branch embolization before 90Y radioembolization: rate of recanalization and new collateral development. Am J Roentgenol 197(1):W169–174CrossRef Petroziello MF, McCann JW, Gonsalves CF et al (2011) Side-branch embolization before 90Y radioembolization: rate of recanalization and new collateral development. Am J Roentgenol 197(1):W169–174CrossRef
20.
Zurück zum Zitat Samuelson SD, Louie JD, Sze DY (2013) N-butyl cyanoacrylate glue embolization of arterial networks to facilitate hepatic arterial skeletonization before radioembolization. Cardiovasc Intervent Radiol 36(3):690–698PubMedCrossRef Samuelson SD, Louie JD, Sze DY (2013) N-butyl cyanoacrylate glue embolization of arterial networks to facilitate hepatic arterial skeletonization before radioembolization. Cardiovasc Intervent Radiol 36(3):690–698PubMedCrossRef
21.
Zurück zum Zitat Lam MG, Banerjee S, Louie JD et al (2013) Root cause analysis of gastroduodenal ulceration after yttrium-90 radioembolization. Cardiovasc Intervent Radiol 36(6):1536–1547PubMedCrossRef Lam MG, Banerjee S, Louie JD et al (2013) Root cause analysis of gastroduodenal ulceration after yttrium-90 radioembolization. Cardiovasc Intervent Radiol 36(6):1536–1547PubMedCrossRef
22.
Zurück zum Zitat McWilliams JP, Kee ST, Loh CT, Lee EW, Liu DM (2011) Prophylactic embolization of the cystic artery before radioembolization: feasibility, safety, and outcomes. Cardiovasc Intervent Radiol 34(4):786–792PubMedCentralPubMedCrossRef McWilliams JP, Kee ST, Loh CT, Lee EW, Liu DM (2011) Prophylactic embolization of the cystic artery before radioembolization: feasibility, safety, and outcomes. Cardiovasc Intervent Radiol 34(4):786–792PubMedCentralPubMedCrossRef
23.
24.
Zurück zum Zitat Ahmadzadehfar H, Mohlenbruch M, Sabet A et al (2011) Is prophylactic embolization of the hepatic falciform artery needed before radioembolization in patients with 99mTc-MAA accumulation in the anterior abdominal wall? Eur J Nucl Med Mol Imaging 38(8):1477–1484PubMedCrossRef Ahmadzadehfar H, Mohlenbruch M, Sabet A et al (2011) Is prophylactic embolization of the hepatic falciform artery needed before radioembolization in patients with 99mTc-MAA accumulation in the anterior abdominal wall? Eur J Nucl Med Mol Imaging 38(8):1477–1484PubMedCrossRef
25.
Zurück zum Zitat Sharma AK, Foster TH, Katz A, Lee DE, Waldman DL (2014) Supraumbilical rash caused by nontarget radioembolization to the falciform artery. J Vasc Interv Radiol 25(3):483–484PubMedCrossRef Sharma AK, Foster TH, Katz A, Lee DE, Waldman DL (2014) Supraumbilical rash caused by nontarget radioembolization to the falciform artery. J Vasc Interv Radiol 25(3):483–484PubMedCrossRef
26.
Zurück zum Zitat Leong QM, Lai HK, Lo RG, Teo TK, Goh A, Chow PK (2009) Radiation dermatitis following radioembolization for hepatocellular carcinoma: a case for prophylactic embolization of a patent falciform artery. J Vasc Interv Radiol 20(6):833–836PubMedCrossRef Leong QM, Lai HK, Lo RG, Teo TK, Goh A, Chow PK (2009) Radiation dermatitis following radioembolization for hepatocellular carcinoma: a case for prophylactic embolization of a patent falciform artery. J Vasc Interv Radiol 20(6):833–836PubMedCrossRef
27.
Zurück zum Zitat Wang DS, Louie JD, Kothary N, Shah RP, Sze DY (2013) Prophylactic topically applied ice to prevent cutaneous complications of nontarget chemoembolization and radioembolization. J Vasc Interv Radiol 24(4):596–600PubMedCrossRef Wang DS, Louie JD, Kothary N, Shah RP, Sze DY (2013) Prophylactic topically applied ice to prevent cutaneous complications of nontarget chemoembolization and radioembolization. J Vasc Interv Radiol 24(4):596–600PubMedCrossRef
28.
Zurück zum Zitat Lau WY, Kennedy AS, Kim YH et al (2012) Patient selection and activity planning guide for selective internal radiotherapy with yttrium-90 resin microspheres. Int J Radiat Oncol Biol Phys 82(1):401–407PubMedCrossRef Lau WY, Kennedy AS, Kim YH et al (2012) Patient selection and activity planning guide for selective internal radiotherapy with yttrium-90 resin microspheres. Int J Radiat Oncol Biol Phys 82(1):401–407PubMedCrossRef
29.
Zurück zum Zitat Giammarile F, Bodei L, Chiesa C et al (2011) EANM procedure guideline for the treatment of liver cancer and liver metastases with intra-arterial radioactive compounds. Eur J Nucl Med Mol Imaging 38(7):1393–1406PubMedCrossRef Giammarile F, Bodei L, Chiesa C et al (2011) EANM procedure guideline for the treatment of liver cancer and liver metastases with intra-arterial radioactive compounds. Eur J Nucl Med Mol Imaging 38(7):1393–1406PubMedCrossRef
30.
Zurück zum Zitat Kennedy A, Nag S, Salem R et al (2007) Recommendations for radioembolization of hepatic malignancies using yttrium-90 microsphere brachytherapy: a consensus panel report from the radioembolization brachytherapy oncology consortium. Int J Radiat Oncol Biol Phys 68(1):13–23PubMedCrossRef Kennedy A, Nag S, Salem R et al (2007) Recommendations for radioembolization of hepatic malignancies using yttrium-90 microsphere brachytherapy: a consensus panel report from the radioembolization brachytherapy oncology consortium. Int J Radiat Oncol Biol Phys 68(1):13–23PubMedCrossRef
31.
Zurück zum Zitat Kennedy AS, McNeillie P, Dezarn WA et al (2009) Treatment parameters and outcome in 680 treatments of internal radiation with resin 90Y-microspheres for unresectable hepatic tumors. Int J Radiat Oncol Biol Phys 74(5):1494–1500PubMedCrossRef Kennedy AS, McNeillie P, Dezarn WA et al (2009) Treatment parameters and outcome in 680 treatments of internal radiation with resin 90Y-microspheres for unresectable hepatic tumors. Int J Radiat Oncol Biol Phys 74(5):1494–1500PubMedCrossRef
32.
Zurück zum Zitat Kao YH, Tan EH, Ng CE, Goh SW (2011) Clinical implications of the body surface area method versus partition model dosimetry for yttrium-90 radioembolization using resin microspheres: a technical review. Ann Nucl Med 25(7):455–461PubMedCrossRef Kao YH, Tan EH, Ng CE, Goh SW (2011) Clinical implications of the body surface area method versus partition model dosimetry for yttrium-90 radioembolization using resin microspheres: a technical review. Ann Nucl Med 25(7):455–461PubMedCrossRef
33.
Zurück zum Zitat Garin E, Lenoir L, Edeline J et al (2013) Boosted selective internal radiation therapy with 90Y-loaded glass microspheres (B-SIRT) for hepatocellular carcinoma patients: a new personalized promising concept. Eur J Nucl Med Mol Imaging 40(7):1057–1068PubMedCentralPubMedCrossRef Garin E, Lenoir L, Edeline J et al (2013) Boosted selective internal radiation therapy with 90Y-loaded glass microspheres (B-SIRT) for hepatocellular carcinoma patients: a new personalized promising concept. Eur J Nucl Med Mol Imaging 40(7):1057–1068PubMedCentralPubMedCrossRef
34.
Zurück zum Zitat Walrand S, Hesse M, Chiesa C, Lhommel R, Jamar F (2014) The low hepatic toxicity per Gray of 90Y glass microspheres is linked to their transport in the arterial tree favoring a nonuniform trapping as observed in posttherapy PET imaging. J Nucl Med 55(1):135–140PubMedCrossRef Walrand S, Hesse M, Chiesa C, Lhommel R, Jamar F (2014) The low hepatic toxicity per Gray of 90Y glass microspheres is linked to their transport in the arterial tree favoring a nonuniform trapping as observed in posttherapy PET imaging. J Nucl Med 55(1):135–140PubMedCrossRef
35.
Zurück zum Zitat Sangro B, Gil-Alzugaray B, Rodriguez J et al (2008) Liver disease induced by radioembolization of liver tumors: description and possible risk factors. Cancer 112(7):1538–1546PubMedCrossRef Sangro B, Gil-Alzugaray B, Rodriguez J et al (2008) Liver disease induced by radioembolization of liver tumors: description and possible risk factors. Cancer 112(7):1538–1546PubMedCrossRef
37.
Zurück zum Zitat Gil-Alzugaray B, Chopitea A, Inarrairaegui M et al (2013) Prognostic factors and prevention of radioembolization-induced liver disease. Hepatology 57(3):1078–1087PubMedCrossRef Gil-Alzugaray B, Chopitea A, Inarrairaegui M et al (2013) Prognostic factors and prevention of radioembolization-induced liver disease. Hepatology 57(3):1078–1087PubMedCrossRef
38.
Zurück zum Zitat Lam MG, Louie JD, Iagaru AH, Goris ML, Sze DY (2013) Safety of repeated yttrium-90 radioembolization. Cardiovasc Intervent Radiol 36(5):1320–1328PubMedCrossRef Lam MG, Louie JD, Iagaru AH, Goris ML, Sze DY (2013) Safety of repeated yttrium-90 radioembolization. Cardiovasc Intervent Radiol 36(5):1320–1328PubMedCrossRef
39.
Zurück zum Zitat Piana PM, Gonsalves CF, Sato T et al (2011) Toxicities after radioembolization with yttrium-90 SIR-spheres: incidence and contributing risk factors at a single center. J Vasc Interv Radiol 22(10):1373–1379PubMedCrossRef Piana PM, Gonsalves CF, Sato T et al (2011) Toxicities after radioembolization with yttrium-90 SIR-spheres: incidence and contributing risk factors at a single center. J Vasc Interv Radiol 22(10):1373–1379PubMedCrossRef
40.
Zurück zum Zitat Lam MG, Abdelmaksoud MH, Chang DT et al (2013) Safety of 90Y radioembolization in patients who have undergone previous external beam radiation therapy. Int J Radiat Oncol Biol Phys 87(2):323–329PubMedCrossRef Lam MG, Abdelmaksoud MH, Chang DT et al (2013) Safety of 90Y radioembolization in patients who have undergone previous external beam radiation therapy. Int J Radiat Oncol Biol Phys 87(2):323–329PubMedCrossRef
41.
Zurück zum Zitat Medical LCS (undated) SIR-Spheres training program: physicians and institutions. Sirtex Medical Medical LCS (undated) SIR-Spheres training program: physicians and institutions. Sirtex Medical
42.
Zurück zum Zitat Dezarn WA, Cessna JT, DeWerd LA et al (2011) Recommendations of the American Association of Physicists in Medicine on dosimetry, imaging, and quality assurance procedures for 90Y microsphere brachytherapy in the treatment of hepatic malignancies. Med Phys 38(8):4824–4845PubMedCrossRef Dezarn WA, Cessna JT, DeWerd LA et al (2011) Recommendations of the American Association of Physicists in Medicine on dosimetry, imaging, and quality assurance procedures for 90Y microsphere brachytherapy in the treatment of hepatic malignancies. Med Phys 38(8):4824–4845PubMedCrossRef
Metadaten
Titel
How to Prepare a Patient for Transarterial Radioembolization? A Practical Guide
verfasst von
Alban Denys
Marc Pracht
Rafael Duran
Boris Guiu
Salim Adib
Ariane Boubaker
Pierre Bize
Publikationsdatum
01.08.2015
Verlag
Springer US
Erschienen in
CardioVascular and Interventional Radiology / Ausgabe 4/2015
Print ISSN: 0174-1551
Elektronische ISSN: 1432-086X
DOI
https://doi.org/10.1007/s00270-015-1071-x

Weitere Artikel der Ausgabe 4/2015

CardioVascular and Interventional Radiology 4/2015 Zur Ausgabe

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.